Procopio’s Life Sciences attorneys bring decades of law firm and in-house counsel experience to their life sciences clients—from life-saving pharmaceuticals to breakthrough biotechnologies—offering a unique understanding of the legal challenges and opportunities in this rapidly evolving, multidisciplinary industry. We counsel clients from emerging companies to established multinationals and from traditional pharmaceutical developers to medical device designers and manufacturers, innovators in the biologics, small molecule, genomic, diagnostic, e-health, digital health technologies and other life sciences industries. Our attorneys provide a wide range of legal services to our clients, including corporate formation, financing and venture capital, intellectual property counseling and litigation, licensing, real estate, mergers and acquisitions, and joint ventures.
Our molecular biology experience includes gene therapy, personalized cancer immunotherapy, TCRs, antibodies/peptibodies; antibody-drug conjugates (ADCs); protein therapeutics, cancer therapies, cellular immunotherapy, nucleic acids, as well as next-generation sequencing and modern genomics. Our chemistry technical expertise includes pharmaceuticals, industrial biotechnology, organic chemistry and polymer chemistry, in areas as diverse as small molecule and peptide pharmaceuticals, adhesives, drug delivery technology, and medical devices. We’ve supported clients at every stage of development from early discovery stage to marketed product.
We are active in the Southern California Life Sciences community and support organizations driving innovation including BIOCOM, LaunchBio, Octane, San Diego Venture Group, SABPA (Sino-American Biotechnology and Pharmaceutical Association), and Women in Bioscience.
Our team includes experienced patent, licensing, trademark, copyright, and trade secret attorneys and patent agents with substantive technical experience in the life sciences industry. In addition, we provide counsel on identification, development, registration, licensing, protection and litigation of IP, including:
- IP due diligence
- Patent portfolio development, maintenance and lifecycle management
- Patent prosecution and opposition strategies
- Freedom to operate & patent landscape analysis
- Patent portfolio management
- Ex-Parte Reexaminations and USPTO Patent Trial and Appeal Board proceedings
- License negotiations
- Structuring and negotiation of technology options and licenses from public institutions
- Non-infringement and invalidity opinions
- Trademarks & copyright compliance and transfer
- Technology licensing, collaborations, M&A and other IP-related transactions
- Copyright registration, licensing, policing, enforcement, compliance and business transactions
- Database law compliance
- IP litigation
We assist inventors and investigators with the structuring and negotiation of technology options and licenses from public institutions. Leveraging our familiarity with the licensing policies and documents, we provide our clients efficient and cost-effective results by concluding license negotiations in an amicable and timely manner while protecting our client’s ability to obtain and retain all rights necessary to achieve their business plan.
FORMATION AND FUNDING
We assist startups and emerging life sciences companies in all areas of corporate and securities, from initial incorporation through seed and angel investments, to mergers and acquisitions (M&A) services. We leverage relationships with premier angel investors, venture capital firms and other sources of debt and equity funding to bring together life sciences entrepreneurs and investors.
M&A AND JOINT VENTURES
Our Mergers & Acquisitions (M&A) attorneys have closed hundreds of deals totaling billions of dollars, from $5 million to more than $1 billion, offering the infrastructure to support smaller and mid-sized companies as well as multinationals. We work actively with Life Sciences clients to determine the best strategies for acquisition or sale, as well as possible strategic joint ventures.
“For the past decade, through multiple rounds of financing, and ultimately leading to the FDA’s approval of our Banyan BTI™, we’ve counted on Procopio for critical legal guidance and counsel. When your venture aims to do something no one has done before—in our case, develop and commercialize the first-ever in vitro diagnostic blood test to aid in the evaluation of patients with suspected TBI, also known as concussion—you want an attorney and a law firm that will take the time to understand your unique needs and clear legal roadblocks before you can even anticipate them. That’s what we’ve come to rely on Procopio.”
- Steven P. Richieri, President and COO Banyan Biomarkers, Inc.
“Procopio invested the time to get to know our business and continues to provide sophisticated, tailored business, tax, IP and licensing advice to help us achieve our goals. [It’s] all of the amenities of a large, multi-national firm with the personal, hands-on service of a local advisor.”
- Asa Nordgren, CEO & Cofounder Trice Imaging Inc.
“I can’t say thank you enough for all of Procopio’s efforts and time sacrifice. Everyone at Cliniqa that worked on this deal is appreciative of your persistent dedication to doing things so timely and effectively. You have made this process so much more enjoyable.”
- Dean Harriman, Chief Financial Officer CLINIQA Corporation